Circulating tumour cells in peripheral blood: Potential impact on breast cancer outcome

Clinical and Translational Oncology

Volumn 13, Issue 3, 2011, Pages 204-208

  Serrano, María José ^a,b   Lorente, José Antonio ^a   Rodríguez, Miguel Delgado ^b   Fernández, Ana ^a   Fernández, Mónica ^c   De La Torre, Capilla ^c   Izquierdo, Jaime Fernández ^a   Rovira, Pedro Sánchez ^c  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

^c University Hospital   (Spain)

Author keywords

Breast cancer; Chemotherapy; Circulating tumour cells; Metastasis; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CELL SEPARATION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL CIRCULATION; PROGNOSIS; RISK ASSESSMENT; TREATMENT DURATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79958214005     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0641-x     Document Type: Article

References (28)

1. Braun S, Vogl F, Naume B et al (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353:793-802 (Pubitemid 41215488)
2. Nakagawa T, Martinez S, Goto Y et al (2007) Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res 13:4105-4110 (Pubitemid 47105972)
3. Ignatiadis M, Kallergi G, Ntoulia M et al (2008) Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res 14:2593-2600
4. Serrano M, Sanchez-Rovira P, Delgado-Rodriguez M, Gaforio JJ (2009) Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer patients. Cancer Biol Therapy 8:671-675
5. Pierga J, Bonnetón C, Vincent Salomón A et al (2004) Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res 10:1392-1400 (Pubitemid 38365234)
6. Tewes M, Aktas B, Welt A et al (2009) Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res 115:181-190
7. Konecny G, Pauletti G, Pegram M et al (2003) Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst 95:142-153 (Pubitemid 36193263)
8. Wülfing P, Borchard J, Buerger H et al (2006) Her2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clin Cancer Res 12:1715-1720
9. Gaforio J, Serrano M, Sanchez-Rovira P et al (2003) Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int J Cancer 107:984-990 (Pubitemid 37429841)
10. Xenidis N, Vlachonikolis I, Mavroudis D et al (2003) Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer. Ann Oncol 14:849-855 (Pubitemid 36827199)
11. Pantel K, Muller V, Auer M et al (2003) Detection and clinical implications of early systemic tumor cell dissemination in breast cancer. Clin Cancer Res 9:6326-6334 (Pubitemid 38031816)
12. Riethdorf S, Wikman H, Pantel K (2008) Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 123:1991-2003
13. Schindlbeck C, Kampik T, Janni W et al (2005) Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas. Breast Cancer Res 7:R1174-R1185
14. Woelfle U, Breit E, Zafrakas K (2005) Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients. J Immunol Methods 300:136-145 (Pubitemid 40805594)
15. Rudolph P, MacGrogan G, Bonichon F et al (1999) Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases. Breast Cancer Res Treat 55:61-71 (Pubitemid 29353975)
16. Nagrath S, Sequist LV, Maheswaran S et al (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235-1239
17. Hayes D, Cristofanilli M, Budd G et al (2006) Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12:4218-4224
18. Ashworth T (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 14:146-149
19. Riethdorf S, Pantel K (2008) Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Pathobiology 75:140-148 (Pubitemid 351820732)
20. Xenidis N, Perraki M, Kafousi M et al (2006) Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol 24:3756-3762 (Pubitemid 46622314)
21. Wiedswang G, Borgen E, Schirmer C et al (2005) Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Int J Cancer 118:2013-2019
22. Ring A, Smith I, Dowsett M (2004) Circulating tumour cells in breast cancer. Lancet 5:79-84
23. Cristofanilli M, Hayes D, Budd T et al (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23:1420-1430
24. Cristofanilli M, Broglio K, Guarneri V et al (2007) Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer 7:471-479 (Pubitemid 46424284)
25. Gasent Blesa J, Alberola Candel V, Esteban González E et al (2008) Circulating tumor cells in breast cancer: methodology and clinical repercussions. Clin Transl Oncol 10:399-406
26. Bear H (2008) Measuring circulating tumor cells as a surrogate end point for adjuvanttherapy of breast cancer: what do they mean and what should we do about them? J Clin Oncol 26:1195-1197
27. Gervasoni A, Monasterio Muñoz R, Wengler G et al (2008) Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett 263:267-279
28. Wang J, Wu C, Lu C et al (2006) Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. World J Surg 30:1007-1013 (Pubitemid 43824411)